Intestinal surgery raises hopes of treating type-2 diabetes

Our Bureau Hyderabad | Updated on March 29, 2013

Surender Ugale

A surgery on the intestines is holding out hope of emerging as a new, potent weapon to fight type-2 diabetes in patients, according to Surendra Ugale, who has so far done around 250 procedures globally.

Known as Ileal Interposition (metabolic surgery), the technique is steadily gaining acceptance, he told newspersons on Friday. A Turkish Hospital has also adopted the technique and “we have trained professionals and about 150 surgeries were performed there”, he said.

Surendra Ugale of the Kirloskar Hospital here said, at present, the procedure is being performed in only six places by 8 people in the world, including himself. It has been in vogue for the past decade. He claimed that with the high incidence of type-2 diabetes, the procedure can be very useful.

The Ileal transposition (or small intestinal switch) is a procedure that utilises a segment of the small intestine tract between the stomach and the ileum, shifts it into an upper area or puts it in line again. The surgery results in a biochemical process that facilitates insulin secretion in the presence of undigested food and controls type-2 diabetes, he explained.

About 90 per cent of all the patients with this type of diabetes can qualify for the surgery. However, it is best suited for those with a progressive problem. A couple of patients who underwent the surgery also shared their experiences and said they could give up medicines and lead an improved life.


Published on March 29, 2013

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like